Physician profile
Leon D Ingham
NPI 1831229913
$1,795.69
in general payments reported to CMS, 2019-2025
16 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $123 · 2021: $200 · 2022: $490 · 2023: $172 · 2024: $259 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Entertainment: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.26 |
| Entertainment | $110.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $336.78 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $330.76 | 2022-2025 | Infuse, Biotrue One Day, Btod |
| Sight Sciences, INC. | $188.79 | 2021-2024 | Omni Surgical System, Tearcare System |
| Coopervision INC. | $180.00 | 2021-2025 | Myday Contact Lens |
| Abbvie INC. | $179.01 | 2022 | |
| Optos, INC. | $110.73 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rxsight INC | $101.79 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Tarsus Pharmaceuticals, INC. | $96.22 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $78.13 | 2020-2023 | Total30 |
| Biotissue Holdings INC. | $57.11 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.07 | 2019-2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tearlab Corp | $19.00 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Allergan, INC. | $16.90 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Ingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.